Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?
Clin. biomed. res
;
42(3): 296-298, 2022.
Article
Dans Anglais
| LILACS
| ID: biblio-1416978
ABSTRACT
Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford-AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the dissemination of this case is of paramount importance.
Sujets)
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Pityriasis rosé
/
Vaccins contre la COVID-19
/
Vaccin ChAdOx1 nCoV-19
Limites du sujet:
Adulte
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Clin. biomed. res
Thème du journal:
Médicament
Année:
2022
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Hospital Santa Casa de Misericórdia de Porto Alegre/BR
/
Irmandade Santa Casa de Misericórdia de Porto Alegre/BR
/
Universidade Federal de Ciências da Saúde de Porto Alegre/BR
/
Universidade Luterana do Brasil/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS